Vimab Group AB (OSTO:VIMAB) Shares Outstanding (EOP): 47.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
47 GF Score
Price kr2.97
GF Value kr6.01
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vimab Group AB Shares Outstanding (EOP)?

Vimab Group AB OSTO:VIMAB +8.00% 47 Shares Outstanding (EOP) is 47.6 Mil as of Mar. 2026. GuruFocus rates OSTO:VIMAB with a GF Score™ of 47/100 and a GF Value™ of kr6.01 (Possible Value Trap). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Vimab Group AB's shares outstanding for the quarter that ended in Mar. 2026 was 47.6 Mil.

Vimab Group AB's quarterly shares outstanding increased from Dec. 2025 (26.5 Mil) to Mar. 2026 (47.6 Mil). It means Vimab Group AB issued new shares from Dec. 2025 to Mar. 2026 .

Vimab Group AB's annual shares outstanding increased from Dec. 2024 (23.9 Mil) to Dec. 2025 (26.5 Mil). It means Vimab Group AB issued new shares from Dec. 2024 to Dec. 2025 .


Vimab Group AB  (OSTO:VIMAB) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Vimab Group AB Shares Outstanding (EOP) Related Terms


Vimab Group AB Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Vimab Group AB's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimab Group AB Shares Outstanding (EOP) Chart

Vimab Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.72 19.40 22.33 23.91 26.55

Vimab Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.28 26.28 26.55 26.55 47.56

OSTO:VIMAB vs VRSK, EFX, BAH: Shares Outstanding (EOP) Comparison

For the Consulting Services subindustry, Vimab Group AB's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimab Group AB Shares Outstanding (EOP) vs Business Services Industry

For the Business Services industry and Industrials sector, Vimab Group AB's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Vimab Group AB's Shares Outstanding (EOP) falls into.


OSTO:VIMAB
47GF Score
Vimab Group AB OSTO:VIMAB
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimab Group AB Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 47.6 Mil mean?
Vimab Group AB (OSTO:VIMAB) has a Shares Outstanding (EOP) of 47.6 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Vimab Group AB and its competitors.
Is Vimab Group AB's Shares Outstanding (EOP) too high?
Vimab Group AB's current Shares Outstanding (EOP) is 47.6 Mil. Overall, Vimab Group AB has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Shares Outstanding (EOP) compare to VRSK and EFX?
Vimab Group AB's Shares Outstanding (EOP) of 47.6 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Business Services company?
A good Shares Outstanding (EOP) depends on the Business Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Vimab Group AB and its competitors. Vimab Group AB's current Shares Outstanding (EOP) is 47.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr6.01, compared to a current price of kr2.97 — trading 50.6% below its estimated fair value. The current Shares Outstanding (EOP) is 47.6 Mil. Vimab Group AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current Shares Outstanding (EOP) is 47.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr2.97 is trading 50.6% below its estimated GF Value™ of kr6.01. GuruFocus considers Vimab Group AB to be Possible Value Trap.

Key valuation signals for OSTO:VIMAB:

  • Shares Outstanding (EOP): 47.6 Mil
  • GF Value™: kr6.01 vs. price of kr2.97 (50.6% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
47GF Score

Get the complete analysis for OSTO:VIMAB

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.97
Price
kr6.01
GF Value